NB

Nandkumar Baburao Gogade

Active Director Director DIN 08214902
DIN 08214902 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Nandkumar Baburao Gogade

Data last updated:

Nandkumar Baburao Gogade is a Director at Astire Pharmaceutical Private Limited (since 2018). The company operates in Pharma.

DIN 08214902
Primary Designation Director
Industry Pharma
First Appointment 04 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Sep 20182018Active

Directorship timeline

Open interactive timeline →
Astire Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Nandkumar Baburao Gogade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandkumar Baburao Gogade

Nandkumar Baburao Gogade currently holds 1 directorship: Astire Pharmaceutical Private Limited (Director, since 04 Sep 2018).

Nandkumar Baburao Gogade was first appointed on 04 Sep 2018 as Director at Astire Pharmaceutical Private Limited.

The current boards of Nandkumar Baburao Gogade's companies include Bhausaheb Kashinath Mitke (Astire Pharmaceutical Private Limited), Sahebrao Shamrao Kadam (Astire Pharmaceutical Private Limited), Shashikant Shivajirao Surwase (Astire Pharmaceutical Private Limited), Yogita Santosh Khadangle (Astire Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available